PMID: 11606862Oct 19, 2001Paper

Focal nodular hyperplasia of the liver after intraconazole treatment

Journal of Clinical Gastroenterology
R WolfS Kuperman

Abstract

A 38-year-old woman developed focal nodular hyperplasia of the liver after she had received a 4-month treatment with intraconazole 200 mg/d for a fungal infection of her fingernails. Because the patient underwent yearly liver ultrasound examinations because of the removal of a breast carcinoma, when the tumor was discovered incidentally, it was clear that it had developed within the past year after she had begun receiving intraconazole. Although various chemical agents and drugs have been considered as possible etiologic factors in the development of focal nodular hyperplasia of the liver, cases occurring after intraconazole therapy have not been reported before. Apart from the theoretical considerations with regard to the pathogenesis of nodular hyperplasia of the liver, this case could gain practical importance, as it shows a new adverse effect of a drug that has been used in more than 34 million patients over the past 10 years. Furthermore, this case should draw attention to the possibility of drug-induced benign hepatic tumors, as they may mimic malignant and metastatic disorders, which might be especially alarming in patients undergoing routine examinations after removal of malignant tumors, such as our patient.

References

Jul 1, 1976·Journal of Clinical Pathology·E C Sweeney, D J Evans
Jan 1, 1979·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·P Grasso
Feb 15, 1977·International Journal of Cancer. Journal International Du Cancer·L RossiL Santi
Jul 25, 1992·Lancet·F R Frankenburg, J Kando
Jul 25, 1992·Lancet·A P LavrijsenB H Stricker
May 1, 1991·The American Journal of Surgical Pathology·C A MoranK G Ishak
Oct 1, 1990·The Journal of Antimicrobial Chemotherapy·R M TuckerD A Stevens
Jan 1, 1989·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R TruhautJ Caldwell
Apr 1, 1986·Archives of Dermatology·A RestrepoR Gutiérrez
May 1, 1985·Carcinogenesis·W F BusbyG N Wogan
Oct 1, 1984·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·E T KimuraP K Cusick
Aug 1, 1995·International Journal of Dermatology·S Gallardo-QuesadaC Guanyabens-Calvet
Nov 1, 1994·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·S W CasteelG E Rottinghaus
Oct 1, 1993·The British Journal of Dermatology·B RamsayJ J Cream
Oct 1, 1993·The British Journal of Dermatology·S K HannY K Park
Jul 1, 1993·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·S W CasteelG E Rottinghaus
Nov 14, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·F M HechtW Powderly
Dec 23, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A RavaioliG Drudi
Jul 29, 1999·Journal of the American Podiatric Medical Association·D A Albreski, E G Gross
Jul 30, 1999·Journal of the American Academy of Dermatology·A K GuptaN H Shear
Dec 11, 1999·Dermatology : International Journal for Clinical and Investigative Dermatology·A K GuptaP De Doncker
Dec 22, 1999·The American Journal of Gastroenterology·J A TalwalkarC L Berg

❮ Previous
Next ❯

Citations

Jun 8, 2002·Pharmacoepidemiology and Drug Safety
Dec 2, 2004·Indian Journal of Pediatrics·A S M Bazlul KarimM Kamal
Jun 7, 2006·Biological & Pharmaceutical Bulletin·Poongavanam VasanthanathanSathish Gopalrao Kaskhedikar
Feb 9, 2010·Journal of Vascular and Interventional Radiology : JVIR·Pejman HedayatiWilliam McMullen
Aug 19, 2005·Expert Review of Anti-infective Therapy·Adolfo C Fernandez-ObregonCarolyn Willis
Apr 17, 2004·Journal of Clinical Gastroenterology·Manuel Jiménez-SáenzJuan Manuel Herrerías-Gutiérrez
Jun 30, 2005·The American Journal of Gastroenterology·Ayse L MindikogluEugene R Schiff
Apr 6, 2006·Chemical & Pharmaceutical Bulletin·Poongavanam VasanthanathanSathish Gopalrao Kaskhedikar
Sep 29, 2007·Journal of Medicinal Chemistry·Bin YaoHui Tang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Gastroenterology & Hepatology
Céline Savoye-ColletJean-Nicolas Dacher
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
S KavukçuM Türkmen
The New England Journal of Medicine
W A High, S D Weiss
© 2021 Meta ULC. All rights reserved